HYMAN CHARLES D - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 77 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
HYMAN CHARLES D ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q3 2018$19,000
+11.8%
15,1430.0%0.00%0.0%
Q2 2018$17,000
-43.3%
15,1430.0%0.00%
-33.3%
Q1 2018$30,000
+66.7%
15,1430.0%0.00%
+50.0%
Q4 2017$18,000
-5.3%
15,1430.0%0.00%0.0%
Q3 2017$19,000
-5.0%
15,1430.0%0.00%
-33.3%
Q2 2017$20,000
-28.6%
15,1430.0%0.00%
-25.0%
Q1 2017$28,000
-64.1%
15,1430.0%0.00%
-63.6%
Q4 2016$78,00015,1430.01%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q1 2017
NameSharesValueWeighting ↓
22NW, LP 155,000$206,0000.12%
Birchview Capital, LP 128,000$170,0000.09%
CARL DOMINO INC 43,273$58,0000.07%
NORTHERN CAPITAL MANAGEMENT LLC 106,050$141,0000.05%
ELEMENT CAPITAL MANAGEMENT LLC 124,423$165,0000.03%
Baker Brothers Advisors 1,618,089$2,152,0000.02%
SIMON QUICK ADVISORS, LLC 24,390$32,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 31,390$42,0000.02%
WHITE PINE CAPITAL LLC 20,000$27,0000.01%
LMR Partners LLP 112,265$149,0000.01%
View complete list of AEVI GENOMIC MEDICINE INC shareholders